Drawbacks of bisphosphonate holidays, bone benefits of the Mediterranean diet, and a new weapon against glucocorticoid-induced osteoporosis.
Mark L. Fuerst
What’s new: advances in serodiagnostic testing, role of T cell activation in Lyme arthritis, and post-treatment Lyme disease syndrome.
Researchers have set their sights on macrophage activation syndrome, pathways identified in renal cells, and mechanistic target of rapamycin.
Role of Epstein-Barr virus in autoimmune diseases, impact of consensus treatment plans, and the search for biomarkers for juvenile arthritis.
Which type of physical activity best relieves symptoms? What underlies the hypersensitivity of fibromyalgia? Recent studies offer answers.
What’s new: cognitive behavioral therapy can combat opioid misuse, virtual reality provides an escape from pain, and an app helps prevent painful sports injuries.
What's new: reliable outcome measures, overlap in treatment targets, and immune checkpoint inhibitors.
Among the highlights of 3 recent studies: insights into hormonal risk factors for rheumatoid arthritis.
Highlights of 3 recent studies that can affect your practice: a novel procedure for knee pain, cardiovascular risk in RA, and febuxostat in early gout.
An expanded role for MRI and 2 recently approved treatment options.